At defined coronal sections, the surface area of infarcted tissue was measured 4 days after the occlusion of the middle cerebral artery in 11 cats. In groups of cats treated with ifenprodil (5.6 and 16.7 µg/kg • min over 3 h, 5 min after the occlusion), the infarcted surface was significantly decreased. The topographic localization of the infarction was studied in control and treated cats. This established necrosis was correlated with measures of focal cerebral blood flow and glucose consumption 3.5 h after the middle cerebral artery occlusion. Grey matter blood flow was universally low in untreated cats, but in cats treated with ifenprodil (5.6 µg/kg • min) cortical and caudate nucleus blood flow was 2–3 times greater, even in those regions that were later infarcted in the treated cats. Glucose consumption was similarly reduced in untreated cats but there was little difference between the control and drug-treated cats except in some areas where drug treatment appeared to further reduce the values for focal glucose consumption. These regions correlated with those in which infarction was later found in the cats treated with ifenprodil. It is hoped that such correlations between pathology, flow and metabolism could help in the search for effective pharmacotherapy of cerebrovascular disease.

Keywords:
Focal ischemia, Cerebral infarction, Neuropathological, Local cerebral blood flow, Cerebral glucose consumption
This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.